Загрузка...
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
Among currently available vaccine strategies for cancer, nucleotide-based vaccination is an appealing treatment modality. Curevacs’ mRNA containing vaccines (RNActive®) combine the beneficial properties of sufficient antigen-expression, autologous immune-stimulation and a high flexibility with respe...
Сохранить в:
| Опубликовано в: : | Hum Vaccin Immunother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514038/ https://ncbi.nlm.nih.gov/pubmed/25483661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29553 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|